Virtus ETF Advisers LLC Immunity Bio, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 56,107 shares of IBRX stock, worth $251,920. This represents 0.1% of its overall portfolio holdings.

Number of Shares

56,107

Previous 56,107 -0.0%

Holding current value

$251,920

Previous $354,000 41.24%

% of portfolio

0.1%

Previous 0.18%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.82 - $9.15 $167,817 - $318,575	34,817 Added 163.54%	56,107 $354,000
Q1 2024 May 15, 2024	SELL	$3.23 - $6.17 $4,706 - $8,989	-1,457 Reduced 6.41%	21,290 $114,000
Q4 2023 Feb 15, 2024	SELL	$1.25 - $5.21 $14,642 - $61,029	-11,714 Reduced 33.99%	22,747 $114,000
Q3 2023 Nov 07, 2023	SELL	$1.29 - $3.1 $4,420 - $10,623	-3,427 Reduced 9.05%	34,461 $58,000
Q2 2023 Aug 14, 2023	BUY	$1.53 - $6.41 $35,004 - $146,654	22,879 Added 152.44%	37,888 $105,000
Q1 2023 May 15, 2023	SELL	$1.35 - $4.78 $7,793 - $27,594	-5,773 Reduced 27.78%	15,009 $27,000
Q4 2022 Feb 14, 2023	SELL	$4.35 - $6.77 $62,057 - $96,580	-14,266 Reduced 40.7%	20,782 $105,000
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $908 - $1,601	249 Added 0.72%	35,048 $174,000
Q2 2022 Aug 12, 2022	BUY	$2.68 - $6.14 $19,982 - $45,779	7,456 Added 27.27%	34,799 $129,000
Q1 2022 May 16, 2022	SELL	$5.05 - $7.53 $8,211 - $12,243	-1,626 Reduced 5.61%	27,343 $153,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $10.18 $83,490 - $149,900	14,725 Added 103.38%	28,969 $176,000
Q3 2021 Nov 15, 2021	SELL	$9.17 - $14.24 $6,767 - $10,509	-738 Reduced 4.93%	14,244 $139,000
Q2 2021 Aug 10, 2021	SELL	$13.41 - $22.4 $145,739 - $243,443	-10,868 Reduced 42.04%	14,982 $214,000
Q1 2021 May 17, 2021	BUY	$12.83 - $42.25 $331,655 - $1.09 Million	25,850 New	25,850 $614,000

Others Institutions Holding IBRX

# of Institutions

202

Shares Held

70M

Call Options Held

1.68M

Put Options Held

1.31M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Immunity Bio, Inc. Transaction History